fda018-adc
mAbexperimentalADC
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Oct 22, 2021 (NCT05174637)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
- Payload
- Unclear
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06519370 | Phase 3 | Aug 9, 2024 | Fudan University, Shanghai Zhangjiang Biotechnology Limited Company |
| NCT05174637 | Phase 1 | Oct 22, 2021 | Fudan University, Shanghai Zhangjiang Biotechnology Limited Company |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fudan University | Academic/Hospital | 2 | 0 | 2 | 2021 |
| Shanghai Zhangjiang Biotechnology Limited Company | For profit | 2 | 2 | 2 | 2021 |
2 organizations
Page 1 / 1